JP2013532130A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013532130A5 JP2013532130A5 JP2013510364A JP2013510364A JP2013532130A5 JP 2013532130 A5 JP2013532130 A5 JP 2013532130A5 JP 2013510364 A JP2013510364 A JP 2013510364A JP 2013510364 A JP2013510364 A JP 2013510364A JP 2013532130 A5 JP2013532130 A5 JP 2013532130A5
- Authority
- JP
- Japan
- Prior art keywords
- represented
- compound
- pharmaceutically acceptable
- acceptable salt
- structural formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33499110P | 2010-05-14 | 2010-05-14 | |
US61/334,991 | 2010-05-14 | ||
US37074510P | 2010-08-04 | 2010-08-04 | |
US61/370,745 | 2010-08-04 | ||
US37586310P | 2010-08-22 | 2010-08-22 | |
US61/375,863 | 2010-08-22 | ||
PCT/US2011/036701 WO2011143669A2 (en) | 2010-05-14 | 2011-05-16 | Compositions and methods for treating neoplasia, inflammatory disease and other disorders |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015049960A Division JP5937247B2 (ja) | 2010-05-14 | 2015-03-12 | 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2013532130A JP2013532130A (ja) | 2013-08-15 |
JP2013532130A5 true JP2013532130A5 (ru) | 2014-11-06 |
JP5715241B2 JP5715241B2 (ja) | 2015-05-07 |
Family
ID=49052897
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013510364A Active JP5715241B2 (ja) | 2010-05-14 | 2011-05-16 | 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法 |
JP2015049960A Active JP5937247B2 (ja) | 2010-05-14 | 2015-03-12 | 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015049960A Active JP5937247B2 (ja) | 2010-05-14 | 2015-03-12 | 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法 |
Country Status (1)
Country | Link |
---|---|
JP (2) | JP5715241B2 (ru) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX362384B (es) | 2010-05-14 | 2019-01-15 | Dana Farber Cancer Inst Inc | Composiciones y metodos para tratar neoplasias, enfermedades inflamatorias y otros trastornos. |
WO2011143651A1 (en) * | 2010-05-14 | 2011-11-17 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for modulating metabolism |
EP2863923B1 (en) * | 2012-06-25 | 2019-05-08 | Oncoethix GmbH | Thienotriazolodiazepine compounds for the treatment of lymphomas |
EP3030242A1 (en) * | 2013-08-06 | 2016-06-15 | Oncoethix GmbH | Method of treating diffuse large b-cell lymphoma (dlbcl) using a bet-bromodomain inhibitor |
CN105849110B (zh) | 2013-11-08 | 2019-08-02 | 达纳-法伯癌症研究所有限公司 | 使用溴结构域和额外终端(bet)蛋白抑制剂的用于癌症的组合疗法 |
CA2940472A1 (en) | 2014-02-28 | 2015-09-03 | Tensha Therapeutics, Inc. | Treatment of conditions associated with hyperinsulinaemia |
EP3314005A1 (en) * | 2015-06-26 | 2018-05-02 | Tensha Therapeutics, Inc. | Treatment of nut midline carcinoma |
KR20180051576A (ko) | 2015-09-11 | 2018-05-16 | 다나-파버 캔서 인스티튜트 인크. | 아세트아미드 티에노트리아졸로디아제핀 및 그의 용도 |
CA2996974A1 (en) * | 2015-09-11 | 2017-03-16 | Dana-Farber Cancer Institute, Inc. | Cyano thienotriazolodiazepines and uses thereof |
WO2017059319A2 (en) * | 2015-10-02 | 2017-04-06 | Dana-Farber Cancer Institute, Inc. | Combination therapy of bromodomain inhibitors and checkpoint blockade |
CN109071562B (zh) * | 2016-02-15 | 2022-03-22 | 密执安大学评议会 | 作为bet溴结构域抑制剂的稠合1,4-氧氮杂䓬和相关类似物 |
KR20190092429A (ko) * | 2016-12-16 | 2019-08-07 | 에프. 호프만-라 로슈 아게 | 다이아제핀 유도체의 제조 방법 |
CN109503618A (zh) * | 2017-09-14 | 2019-03-22 | 成都海创药业有限公司 | 一种brd4抑制剂 |
CA3102178A1 (en) * | 2018-06-13 | 2019-12-19 | Dybly Ag | Preparation of condensed triazepine derivatives and their use as bet inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0934940A1 (en) * | 1996-06-12 | 1999-08-11 | Japan Tobacco Inc. | Cytokine production inhibitors, triazepine compounds, and intermediates thereof |
US7589167B2 (en) * | 2000-02-22 | 2009-09-15 | J. David Gladstone Institutes | ZA loops of bromodomains |
PL378116A1 (pl) * | 2003-02-27 | 2006-03-06 | Abbott Laboratories | Heterocykliczne inhibitory kinazy |
WO2009084693A1 (ja) * | 2007-12-28 | 2009-07-09 | Mitsubishi Tanabe Pharma Corporation | 抗癌剤 |
EP2496582B1 (en) * | 2009-11-05 | 2016-01-27 | GlaxoSmithKline LLC | Benzodiazepine bromodomain inhibitor |
-
2011
- 2011-05-16 JP JP2013510364A patent/JP5715241B2/ja active Active
-
2015
- 2015-03-12 JP JP2015049960A patent/JP5937247B2/ja active Active